Young RH (May 2004). "Pseudomyxoma peritonei and selected other aspects of the spread of appendiceal neoplasms". Seminars in Diagnostic Pathology. 21 (2): 134–150. doi:10.1053/j.semdp.2004.12.002. PMID15807473.
Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM (December 1995). "Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei"". The American Journal of Surgical Pathology. 19 (12): 1390–1408. doi:10.1097/00000478-199512000-00006. PMID7503361.
Bradley RF, Cortina G, Geisinger KR (October 2007). "Pseudomyxoma peritonei: Review of the controversy". Current Diagnostic Pathology. 13 (5): 410–416. doi:10.1016/j.cdip.2007.05.013.
Panarelli NC, Yantiss RK (October 2011). "Mucinous neoplasms of the appendix and peritoneum". Archives of Pathology & Laboratory Medicine. 135 (10): 1261–1268. doi:10.5858/arpa.2011-0034-RA. PMID21970481. S2CID24335764.
Sugarbaker PH (January 2006). "New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?". The Lancet. Oncology. 7 (1): 69–76. doi:10.1016/S1470-2045(05)70539-8. PMID16389186.
Kusamura S, Baratti D, Hutanu I, Gavazzi C, Morelli D, Iusco DR, et al. (August 2015). "The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)". European Journal of Surgical Oncology. 41 (8): 1097–1105. doi:10.1016/j.ejso.2015.04.005. PMID26026742.
Young RH (May 2004). "Pseudomyxoma peritonei and selected other aspects of the spread of appendiceal neoplasms". Seminars in Diagnostic Pathology. 21 (2): 134–150. doi:10.1053/j.semdp.2004.12.002. PMID15807473.
Ronnett BM, Zahn CM, Kurman RJ, Kass ME, Sugarbaker PH, Shmookler BM (December 1995). "Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei"". The American Journal of Surgical Pathology. 19 (12): 1390–1408. doi:10.1097/00000478-199512000-00006. PMID7503361.
Panarelli NC, Yantiss RK (October 2011). "Mucinous neoplasms of the appendix and peritoneum". Archives of Pathology & Laboratory Medicine. 135 (10): 1261–1268. doi:10.5858/arpa.2011-0034-RA. PMID21970481. S2CID24335764.
Sugarbaker PH (January 2006). "New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?". The Lancet. Oncology. 7 (1): 69–76. doi:10.1016/S1470-2045(05)70539-8. PMID16389186.
Kusamura S, Baratti D, Hutanu I, Gavazzi C, Morelli D, Iusco DR, et al. (August 2015). "The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)". European Journal of Surgical Oncology. 41 (8): 1097–1105. doi:10.1016/j.ejso.2015.04.005. PMID26026742.